ABIVAX Société Anonyme (ABVX.PA)

EUR 7.48

(2.89%)

Operating Expenses Summary of ABIVAX Société Anonyme

  • ABIVAX Société Anonyme's latest annual operating expenses in 2023 was 127.37 Million EUR , up 132.06% from previous year.
  • ABIVAX Société Anonyme's latest quarterly operating expenses in 2024 Q2 was 86.78 Million EUR , down 0.0% from previous quarter.
  • ABIVAX Société Anonyme reported a annual operating expenses of 56.57 Million EUR in annual operating expenses 2022, up 8.73% from previous year.
  • ABIVAX Société Anonyme reported a annual operating expenses of 52.03 Million EUR in annual operating expenses 2021, up 31.63% from previous year.
  • ABIVAX Société Anonyme reported a quarterly operating expenses of 39.2 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • ABIVAX Société Anonyme reported a quarterly operating expenses of 131.28 Million EUR for 2023 FY, up 132.06% from previous quarter.

Annual Operating Expenses Chart of ABIVAX Société Anonyme (2023 - 2013)

Historical Annual Operating Expenses of ABIVAX Société Anonyme (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 127.37 Million EUR 132.06%
2022 56.57 Million EUR 8.73%
2021 52.03 Million EUR 31.63%
2020 39.52 Million EUR 19.08%
2019 33.19 Million EUR 593.59%
2018 4.78 Million EUR 23.26%
2017 3.88 Million EUR 7.77%
2016 3.6 Million EUR -14.17%
2015 4.19 Million EUR -51.4%
2014 8.63 Million EUR 18.14%
2013 7.31 Million EUR 0.0%

Peer Operating Expenses Comparison of ABIVAX Société Anonyme

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -2949.462%
Adocia SA 15.62 Million EUR -714.998%
Aelis Farma SA 18.81 Million EUR -576.848%
Biophytis S.A. 14.33 Million EUR -788.69%
Advicenne S.A. 8.21 Million EUR -1450.53%
genOway Société anonyme 16.73 Million EUR -660.986%
IntegraGen SA 5.35 Million EUR -2279.743%
Medesis Pharma S.A. 1.56 Million EUR -8041.268%
Neovacs S.A. 10.34 Million EUR -1131.454%
NFL Biosciences SA 4.37 Million EUR -2811.882%
Plant Advanced Technologies SA 2.76 Million EUR -4506.977%
Quantum Genomics Société Anonyme 1.71 Million EUR -7314.354%
Sensorion SA 27.05 Million EUR -370.827%
Theranexus Société Anonyme 3 Million EUR -4138.82%
TME Pharma N.V. 5.49 Million EUR -2217.191%
Valbiotis SA 9.86 Million EUR -1190.668%
TheraVet SA 1.64 Million EUR -7646.457%
Valerio Therapeutics Société anonyme 20.32 Million EUR -526.85%
argenx SE 1.34 Billion EUR 90.513%
BioSenic S.A. 7.58 Million EUR -1579.757%
Celyad Oncology SA 8.49 Million EUR -1400.306%
DBV Technologies S.A. 89.4 Million EUR -42.47%
Galapagos NV 327.98 Million EUR 61.164%
Genfit S.A. 54.8 Million EUR -132.421%
GeNeuro SA 14.35 Million EUR -787.186%
Hyloris Pharmaceuticals SA 17.98 Million EUR -608.156%
Innate Pharma S.A. 64.57 Million EUR -97.268%
Inventiva S.A. 120.18 Million EUR -5.982%
MaaT Pharma SA 21.59 Million EUR -489.758%
MedinCell S.A. 32.92 Million EUR -286.902%
Nanobiotix S.A. 58.92 Million EUR -116.159%
Onward Medical N.V. 20.64 Million EUR -516.982%
Oryzon Genomics S.A. 18.49 Million EUR -588.627%
OSE Immunotherapeutics SA 23.58 Million EUR -439.98%
Oxurion NV 12.21 Million EUR -942.869%
Pharming Group N.V. 204.24 Million EUR 37.637%
Poxel S.A. 28.76 Million EUR -342.816%
GenSight Biologics S.A. 32.66 Million EUR -290.006%
Transgene SA 31.23 Million EUR -307.851%
Financière de Tubize SA 114.38 Thousand EUR -111253.364%
UCB SA 2.94 Billion EUR 95.669%
Valneva SE 134.92 Million EUR 5.594%
Vivoryon Therapeutics N.V. 24.69 Million EUR -415.859%